Search the Newsreel

Fair Isaac Corp. stock underperforms Tuesday when compared to competitors

Shares of Fair Isaac Corp. (FICO) fell 1.10% on Tuesday, closing at $1,038.23. This underperformance occurred during a generally negative trading session for the broader market, with both the S&P 500 Index and Dow Jones Industrial Average also declining. The stock's dip ended a …

Artisan Partners Asset Management Inc. Reports July 2026 Assets Under Management

MILWAUKEE, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of July 31, 2026 totaled $183.0 billion. Artisan Funds and Artisan Global Funds accounted for $94.3 billion of total firm …

Form 8K Visa Inc Class A For: 11 August By Investing.com

This article from Investing.com is a regulatory filing update, specifically a Form 8K for Visa Inc. Class A shares, dated August 11. It indicates that Visa Inc. has submitted this filing, typically used to announce unscheduled material events or corporate changes. The content is …

Visa Inc. (V) vs. Mastercard Incorporated (MA): Same Strong Spending Story, Very Different Stock Reactions

Visa Inc. (NYSE:V) and Mastercard Incorporated (NYSE:MA) both beat Wall Street's profit estimates this earnings season on resilient consumer spending and a World Cup travel boost. However, Visa's stock fell on the news while Mastercard's jumped, and the difference came down to what else …

Will Pismo-DPS Help Visa Capture More of the Banking Value Chain?

Visa Inc. V is focusing on deepening its role in banking infrastructure as it combines the capabilities of Pismo and DPS to address growing demand for modern issuer-processing solutions. The strategy could help Visa expand relationships with smaller and midsized banks and fintechs, giving …

Kaisa Prosperity Sets August Board Meeting to Review Interim Results and Dividend

Visa's Cheaper Multiple Rests On A Margin Assumption

Image by Julita from Pixabay The forward numbers make the stock look reasonable, but they assume profitability keeps climbing at a company currently spending to grow. Visa (V) stock has lagged the market for a year. It trades at $360.65, and returned about 9.5% …

Should Fair Isaac’s Buybacks And Higher Guidance Amid Scoring Competition Require Action From FICO Investors?

Fair Isaac Corporation reported strong Q3 2026 results with US$674.19 million in revenue and US$237.17 million net income, along with increased full-year guidance and over US$2.69 billion in share repurchases. Despite this positive financial performance, concerns persist among investors regarding competitive pressures in credit …

Alogram Joins FICO Marketplace to Deepen Explainable Fraud Intelligence

Alogram Inc. has announced that its suite of fraud intelligence offerings is now available on FICO® Marketplace, providing enterprises with explainable, audit-ready evidence to combat emerging fraud. These specialized AI offerings, including Account Forensics and Behavioral Intelligence, help organizations understand suspicious digital activity and …

What Artisan Partners Asset Management (APAM)'s Stronger Q2 2026 Earnings Means For Shareholders

Artisan Partners Asset Management reported stronger Q2 2026 earnings with increased revenue and net income, supporting its investment narrative of an expanded platform. Despite positive short-term results, risks remain regarding asset flows and pricing pressure in active management, as well as the sustainability of …

Paisalo Digital Q1FY27: AUM surges 28%, disbursements jump 128%

Palisade Bio Q2 Net Loss Expands; Plans Phase 2 ASCENTRA-UC Trial Enrollment In H2 2026; Stock Down

(RTTNews) - Palisade Bio, Inc. (PALI), a clinical-stage biopharmaceutical company, reported financial results for the second quarter ended June 30, 2026, reflecting a wider net loss and provided a business update. Company Profile Palisade Bio develops prodrugs for patients living with inflammatory and fibrotic …

Energisa Mato Grosso Distribuidora de Energia SA (BSP:ENMT3) (Q2 2026) Earnings Call ...

This article first appeared on GuruFocus. Recurring Adjusted EBITDA: Reached $1.99 billion, up 1.4% year-over-year. Recurring Adjusted Net Income: Totaled $88 million in the quarter, down 80% compared to the second quarter of '25. Net Debt: Reached $32.5 billion at the end of June. …

FICO Trades at Half Its High on a Threat With a Ceiling. Is That the Opportunity?

FICO's stock has fallen significantly from its peak due to concerns over competition from VantageScore in the mortgage lending sector, despite the company reporting strong quarterly results and raising full-year guidance. While analysts have downgraded the stock, FICO maintains that its newest model, Score …

Palisade Bio plans phase 2 ulcerative colitis trial in 2H 2026

Palisade Bio (NASDAQ:PALI) announced plans to initiate a Phase 2 clinical trial for its drug candidate PALI-2108 in ulcerative colitis during the second half of 2026, with results expected in late 2027. The company also intends to file an investigational new drug application for …

Palisade Bio (NASDAQ:PALI) Releases Quarterly Earnings Results, Hits Expectations

Palisade Bio (NASDAQ:PALI) announced its quarterly earnings, reporting a loss of $0.05 per share, which met analyst expectations, and revenue of $0.50 million. The stock saw a slight dip, trading down 0.5% to $2.10, while analysts maintain an overall "Buy" rating with a target …

Palisade Bio Q2 Results: Net loss widens to $10.6 million on R&D surge

Palisade Bio (NASDAQ: PALI) reported a Q2 2026 net loss of $10.6 million, significantly wider than the $2.8 million loss in Q2 2025, primarily due to increased R&D expenses for its lead candidate, PALI-2108. Despite the widening loss, the company's EPS of $(0.05) met …

PALISADE BIO, INC. Q2 2026: Revenue $0.5M, EPS $(0.05) — 10-Q Summary

PALISADE BIO, INC. (PALI) reported second-quarter 2026 financial results with $0.5 million in revenue and a net loss of $10.6 million, or $(0.05) diluted EPS. This marks an increase in revenue compared to the year-ago quarter, though the net loss widened. The company also …

Palisade Bio expects once-daily drug trial for bowel disease to start in 2H

Palisade Bio reported Q2 2026 financial results, including a net loss of $10.6 million, and provided an update on its lead Inflammatory Bowel Disease (IBD) candidate, PALI-2108. The company plans to initiate Phase 2 ASCENTRA-UC trials for ulcerative colitis in the second half of …

LİNK BİLGİSAYAR SİSTEMLERİ YAZILIMI VE DONANIMI SANAYİ VE TİCARET A.Ş. Sorumluluk Beyanı (Konsolide Olmayan) 10 Ağustos 2026

Palisade Bio Reports Second Quarter 2026 Financial Results

Palisade Bio, Inc. reported its second-quarter 2026 financial results, highlighting the continued advancement of PALI-2108 into Phase 2 development for inflammatory bowel disease (IBD). The company expects to begin enrollment for the Phase 2 ASCENTRA-UC trial in the second half of 2026, with primary …

Q2 Rundown: Fair Isaac Corporation (NYSE:FICO) Vs Other Data & Business Process Services Stocks

Q2 Rundown: Fair Isaac Corporation (NYSE:FICO) Vs Other Data & Business Process Services Stocks The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let's take a look at …

Q2 Earnings Outperformers: Visa (NYSE:V) And The Rest Of The Credit Card Stocks

Q2 Earnings Outperformers: Visa (NYSE:V) And The Rest Of The Credit Card Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we are looking at Visa (NYSE:V) and …

ISABELLA BANK CORP Q2 2026: Revenue $30.59M, EPS $0.69— 10-Q Summary

ISABELLA BANK CORP reported its Q2 2026 results, showing a year-over-year revenue increase to $30.59M and diluted EPS of $0.69. The company saw improved lending and investment yields, loan growth driven by commercial and residential real estate, and strategic initiatives including a merger agreement …

Why Visa (V) Could Be a Major Winner in the AI Payments Boom

Brown Advisory, an investment management company, released its "Brown Advisory Global Leaders Strategy" for the second quarter of 2026 investor letter. A copy of the letter can be downloaded here. Brown Advisory's Global Leaders Strategy delivered a net return of 4.6% in the second …

Barclays cuts Fair Isaac stock price target on mortgage pricing outlook

Barclays has lowered its price target for Fair Isaac (NYSE:FICO) stock from $1,950 to $1,700, while maintaining an Overweight rating. The adjustment is primarily due to expectations that mortgage pricing will represent a significant portion of revenue in 2027, followed by a moderation, alongside …

Price-Driven Insight from (FICO) for Rule-Based Strategy

This article provides a price-driven analysis for Fair Isaac Corporation (FICO), suggesting a short bias due to weak sentiment across all horizons. It outlines an exceptional 80.1:1 risk-reward short setup targeting a 23.2% downside with minimal risk. The analysis includes institutional trading strategies like …

Renaissance Technologies LLC Lowers Stake in Palisade Bio, Inc. $PALI

Renaissance Technologies LLC decreased its stake in Palisade Bio, Inc. by 39% in the first quarter, selling 928,100 shares but still owning 1.45 million shares valued at approximately $2.55 million. Despite this, institutional investors collectively hold 11.79% of PALI, and analysts maintain a consensus …

AMERISAFE, Inc. (AMSF) Stock Forecasts

AMERISAFE, Inc. (AMSF) recently had its rating decreased to a SELL by Argus on August 5, 2026. The company specializes in workers' compensation insurance for hazardous industries like construction and trucking. The current stock price is $28.59.

Paisalo Digital BC ecosystem surpasses USD 1 billion in gross transaction value

Price to sales forward of Calisa Acquisition Corp – NASDAQ:ALISR

The article provides a brief financial overview of Calisa Acquisition Corp (NASDAQ: ALISR), specifically highlighting its "Price to sales forward" metric. It appears to be a stub or a data point from TradingView, indicating that the market was closed and no trades had occurred …

Fair Isaac (FICO) Following Strong Q3 And Higher Guidance, Is The Pullback A Valuation Opening?

Behavioral Patterns of APAM and Institutional Flows

This article analyzes the behavioral patterns and institutional flows for Artisan Partners Asset Management Inc. Class A (NASDAQ: APAM). It highlights strong near and mid-term sentiment, but a weak long-term outlook, and provides three AI-generated trading strategies: Position Trading, Momentum Breakout, and Risk Hedging. …

Grupo Televisa, S.A.B. Revenue Breakdown – FWB:TLV1

Grupo Televisa, S.A.B. (FWB:TLV1) generated €2.78 billion in revenue last year, primarily from its Telecom segment. The majority of this revenue, €2.73 billion, came from Mexico. The article provides a high-level overview of the company's financial performance by segment and country.

Fair Isaac Corporation (FICO) latest stock news and headlines

This article provides a compilation of recent news and headlines concerning Fair Isaac Corporation (FICO). It includes stock performance data, a list of various news articles from different sources over the past couple of weeks, and some financial metrics. The news covers FICO's financial …

Intellicheck, Inc. (NASDAQ:IDN) Receives Consensus Rating of "Moderate Buy" from Analysts

Intellicheck, Inc. (NASDAQ:IDN) has received a "Moderate Buy" consensus rating from six analysts, with an average 12-month price target of $7.375, significantly higher than its current share price of $3.93. Despite reporting quarterly earnings in line with estimates and institutional investors increasing their holdings, …